Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 3
1956 1
1957 1
1958 6
1959 4
1960 8
1961 7
1962 4
1963 9
1964 5
1965 4
1966 8
1967 4
1968 9
1969 8
1970 11
1971 15
1972 9
1973 10
1974 7
1975 6
1976 10
1977 9
1978 7
1979 9
1980 12
1981 19
1982 24
1983 17
1984 15
1985 14
1986 8
1987 7
1988 10
1989 6
1990 9
1991 4
1992 8
1993 12
1994 16
1995 44
1996 20
1997 33
1998 31
1999 27
2000 34
2001 47
2002 48
2003 27
2004 41
2005 28
2006 39
2007 46
2008 48
2009 49
2010 42
2011 51
2012 61
2013 54
2014 61
2015 70
2016 77
2017 75
2018 75
2019 93
2020 87
2021 107
2022 105
2023 92
2024 75
2025 85

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,957 results

Results by year

Filters applied: . Clear all
Page 1
The effects of vitrification on oocyte quality.
Chang CC, Shapiro DB, Nagy ZP. Chang CC, et al. Among authors: nagy zp. Biol Reprod. 2022 Feb 22;106(2):316-327. doi: 10.1093/biolre/ioab239. Biol Reprod. 2022. PMID: 34962575 Review.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP; MACH-NC Collaborative Group. Lacas B, et al. Among authors: nagy zt. Radiother Oncol. 2021 Mar;156:281-293. doi: 10.1016/j.radonc.2021.01.013. Epub 2021 Jan 27. Radiother Oncol. 2021. PMID: 33515668 Free PMC article.
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.
Salles G, Duell J, González Barca E, Tournilhac O, Jurczak W, Liberati AM, Nagy Z, Obr A, Gaidano G, André M, Kalakonda N, Dreyling M, Weirather J, Dirnberger-Hertweck M, Ambarkhane S, Fingerle-Rowson G, Maddocks K. Salles G, et al. Among authors: nagy z. Lancet Oncol. 2020 Jul;21(7):978-988. doi: 10.1016/S1470-2045(20)30225-4. Epub 2020 Jun 5. Lancet Oncol. 2020. PMID: 32511983 Clinical Trial.
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study.
Duell J, Abrisqueta P, Andre M, Gaidano G, Gonzales-Barca E, Jurczak W, Kalakonda N, Liberati AM, Maddocks KJ, Menne T, Nagy Z, Tournilhac O, Kuffer C, Bakuli A, Amin A, Gurbanov K, Salles G. Duell J, et al. Among authors: nagy z. Haematologica. 2024 Feb 1;109(2):553-566. doi: 10.3324/haematol.2023.283480. Haematologica. 2024. PMID: 37646664 Free PMC article. Clinical Trial.
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria.
Scheinberg P, Clé DV, Kim JS, Nur E, Yenerel MN, Barcellini W, Bonito D, Giai V, Hus M, Lee Y, Lekue CB, Panse J, Ueda Y, Buatois S, Gentile B, Kiialainen A, Patel H, Sreckovic S, Uguen M, Edwards J, Nagy Z, Kulasekararaj AG. Scheinberg P, et al. Among authors: nagy z. Am J Hematol. 2024 Sep;99(9):1757-1767. doi: 10.1002/ajh.27413. Epub 2024 Jun 25. Am J Hematol. 2024. PMID: 38924124 Free article. Clinical Trial.
[Pachychoroid diseases].
Gergely R, Ecsedy M, Kovács I, Papp A, Resch M, Récsán Z, Szabó A, Nagy ZZ. Gergely R, et al. Among authors: nagy zz. Orv Hetil. 2021 May 16;162(20):770-781. doi: 10.1556/650.2021.32062. Orv Hetil. 2021. PMID: 33999854 Review. Hungarian.
[Ocular paraneoplastic pemphigoid].
Fodor E, Silló P, Lukács A, Kárpáti S, Nagy ZZ, Füst Á. Fodor E, et al. Among authors: nagy zz. Orv Hetil. 2022 May 1;163(18):720-725. doi: 10.1556/650.2022.32441. Print 2022 May 1. Orv Hetil. 2022. PMID: 35490388 Hungarian.
[Ocular syphilis].
Géhl Z, Tamási B, Bánvölgyi A, Nagy ZZ. Géhl Z, et al. Among authors: nagy zz. Orv Hetil. 2020 Nov 8;161(45):1927-1935. doi: 10.1556/650.2020.31892. Print 2020 Nov 8. Orv Hetil. 2020. PMID: 33161392 Hungarian.
Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.
Tapasztó B, Flitcroft DI, Aclimandos WA, Jonas JB, De Faber JHN, Nagy ZZ, Kestelyn PG, Januleviciene I, Grzybowski A, Vidinova CN, Guggenheim JA, Polling JR, Wolffsohn JS, Tideman JWL, Allen PM, Baraas RC, Saunders KJ, McCullough SJ, Gray LS, Wahl S, Smirnova IY, Formenti M, Radhakrishnan H, Resnikoff S, Németh J; SOE Myopia Consensus Group. Tapasztó B, et al. Among authors: nagy zz. Eur J Ophthalmol. 2024 Jul;34(4):952-966. doi: 10.1177/11206721231219532. Epub 2023 Dec 12. Eur J Ophthalmol. 2024. PMID: 38087768 Free PMC article. Review.
1,957 results